Reactant for synthesis of: A coumarin-based HIV-1 Vpr inhibitor1 Antitumor agents as potent chemosensitizers2 Oxime carbamates as reversible inhibitors of fatty acid amide hydrolase3 Dipeptidyl peptidase 4 inhibitors for the treatment of type 2 diabetes4 Bisarylmaleimide glycogen synthase kinase-3 inhibitors5 Lysosomal acid lipase inhibitors and potential Niemann-Pick type C disease therapeutics6
Reactant for synthesis of:
A coumarin-based HIV-1 Vpr inhibitor
Antitumor agents as potent chemosensitizers
Oxime carbamates as reversible inhibitors of fatty acid amide hydrolase
Dipeptidyl peptidase 4 inhibitors for the treatment of type 2 diabetes
Bisarylmaleimide glycogen synthase kinase-3 inhibitors
Lysosomal acid lipase inhibitors and potential Niemann-Pick type C disease therapeutics
